Agfa signs PACS clients

Article

The AntoniusMesosGroup (AMG) has signed a letter of intent with Agfa HealthCare to digitize its radiology departments. By fall 2003, the hospital group, which includes three hospitals in the Netherlands, expects to be completely filmless, implementing

The AntoniusMesosGroup (AMG) has signed a letter of intent with Agfa HealthCare to digitize its radiology departments. By fall 2003, the hospital group, which includes three hospitals in the Netherlands, expects to be completely filmless, implementing Agfa Impax with integrated RIS. The project is valued at Euro 3.75 million. The project initially will install Agfa RIS with speech recognition at each of the sites. AMG's three radiology departments will then be linked with Agfa's Impax system. The next step will be to integrate the RIS and PACS.

In Charleston, WV, the installation of Impax at one site, Charleston Area Medical Center, is leading to its expansion to three others. The Charleston center went filmless in spring 2002. Installation of Impax at the other three hospitals in the nonprofit CAMC Health System could be completed by next spring.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.